- OUTLOOK
The screening imperative for multiple myeloma
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 587, S63 (2020)
doi: https://doi.org/10.1038/d41586-020-03227-y
This article is part of Nature Outlook: Multiple myeloma, an editorially independent supplement produced with the financial support of third parties. About this content.
References
Mateos, M.-V. et al. N. Engl. J. Med. 369, 438–447 (2013).
Lonial, S. et al. J. Clin. Oncol. 38, 1126–1137 (2020).
Landgren, O. et al. Blood Cancer J. 7, e618 (2017).
Landgren, O. et al. Leukemia 28, 1537–1542 (2014).